167 related articles for article (PubMed ID: 9462490)
1. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.
Turner BJ; Markson L; Cocroft J; Cosler L; Hauck WW
J Gen Intern Med; 1998 Jan; 13(1):16-23. PubMed ID: 9462490
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia.
Ewig S; Schäfer H; Rockstroh JK; Pickenhain A; Lüderitz B
Eur Respir J; 1996 May; 9(5):1006-12. PubMed ID: 8793464
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
5. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia.
Fahy JV; Chin DP; Schnapp LM; Steiger DJ; Schaumberg TH; Geaghan SM; Klein JS; Hopewell PC
Am Rev Respir Dis; 1992 Oct; 146(4):844-8. PubMed ID: 1416408
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Moorman AC; Von Bargen JC; Palella FJ; Holmberg SD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):182-8. PubMed ID: 9768629
[TBL] [Abstract][Full Text] [Related]
7. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
Lidman C; Berglund O; Tynell E; Lindbäck S; Elvin K
AIDS; 1994 Jul; 8(7):935-9. PubMed ID: 7946102
[TBL] [Abstract][Full Text] [Related]
9. [HIV-associated Pneumocystis carinii pneumonia, primary pentamidine inhalation prophylaxis notwithstanding. Are there differences with Pneumocystis carinii pneumonia without prophylaxis?].
Ewig S; Rockstroh JK; Schäfer H; Leutner C; Pickenhain A; Lüderitz B
Dtsch Med Wochenschr; 1996 Jan; 121(4):83-9. PubMed ID: 8631243
[TBL] [Abstract][Full Text] [Related]
10. High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
Flamholc L; Haidl S; Westin E; Borgdalen L; Prellner T
Infection; 1992; 20(6):309-12. PubMed ID: 1293048
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
12. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D
Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
[TBL] [Abstract][Full Text] [Related]
15. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK
Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
Yangco BG; Von Bargen JC; Moorman AC; Holmberg SD
Ann Intern Med; 2000 Feb; 132(3):201-5. PubMed ID: 10651600
[TBL] [Abstract][Full Text] [Related]
20. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
